评估草药产品的适用性:对EMA专著和数据库记录进行比较分析
Hai Anh Nguyen1, Jennifer Doerfler2, Jens Buentzel3
1Klinik Für Innere Medizin II, Hämatologie Und Internistische Onkologie, Universitätsklinikum Jena, Friedrich-Schiller-Universität Jena, Am Klinikum 1, Jena, 07747, Deutschland. haianh.nguyen.med@gmail.com.
BMC complementary medicine and therapies
|April 9, 2025
概括
草药 (HMP) 可能有助于管理癌症治疗的副作用. 然而,证据不足以证实,对于一般患者批准的HMP使用是否可以转移到癌症患者.
科学领域:
- 综合性瘤学是一种综合性瘤学.
- 草药药物制品的药监督工作
背景情况:
- 在癌症治疗期间,副作用很常见.
- 草药产品 (HMP) 用于管理治疗诱导的症状.
研究的目的:
- 为了比较欧洲药物管理局 (EMA) 关于医疗保健医师的专著指示与Medline和Cochrane图书馆的发现.
- 调查转移HMP指示从非癌症患者转移到癌症患者的证据,以管理与治疗相关的症状.
主要方法:
- 进行了全面的文献审查.
- 系统的文献搜索从726个记录中确定了96个临床试验.
主要成果:
- 58.3%的试验符合EMA专著的适应症.
- 41.7%的试验报告了癌症患者的非EMA指示.
- 大约71.1%的植物药物被批准作为传统使用的HMP (THMP).
结论:
- 欧洲药品署 (EMA) 的努力提高了欧盟的HMP质量.
- 需要更多的系统研究来产生对HMPs的强有力的证据.
- 数据不足使得无法就将HMP的指示转移到癌症患者身上做出明确的结论.
关键词:
癌症 癌症 癌症 癌症欧洲药品监督管理局 (EMA) 是一个.草本药品是一种草本药品.综合医学是一个整体的医学.列表条目 列表条目这是一本专著 (Monograph) 的专著.植物药品 植物药品更多相关视频
08:55Author Spotlight: Harnessing DNA Barcode Technology to Enhance the Efficiency of Medicinal Plant Identification
Published on: November 1, 2024
1.2K
08:56Detection of Regulated Ergot Alkaloids in Food Matrices by Liquid Chromatography-Trapped Ion Mobility Spectrometry-Time-of-Flight Mass Spectrometry
Published on: November 22, 2024
523
相关概念视频
01:25Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
01:19Pharmacovigilance
753
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
753